Actively Recruiting
Inhaled Isopropyl Alcohol for Treatment of Nausea
Led by State University of New York at Buffalo · Updated on 2025-10-08
84
Participants Needed
1
Research Sites
218 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To determine the efficacy of inhaled isopropyl alcohol in treating nausea/vomiting among pediatric patients compared with the conventional ondansetron, or placebo treatment in a tertiary care pediatric emergency department.
CONDITIONS
Official Title
Inhaled Isopropyl Alcohol for Treatment of Nausea
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a chief complaint of nausea or vomiting
- Ages 7 to 17 years, both sexes
- Weight greater than or equal to 15 kg
- Baxter Animated Retching Faces (BARF) nausea severity score greater than or equal to 4 out of 10
You will not qualify if you...
- Require intravenous (IV) access
- Inability to breathe in and out through the nose
- Anosmia (loss of smell) reported by patient or parent
- Allergy to isopropyl alcohol or ondansetron
- Current or past alcohol abuse
- Inability to communicate feeling nauseous
- Inability to follow directions for deep nasal breathing
- Known prolonged QT interval heart condition
- Pregnancy
- Received antiemetics within the last 8 hours
- Currently taking apomorphine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oishei Children's Hospital
Buffalo, New York, United States, 14203
Actively Recruiting
Research Team
H
Haiping Qiao, MBBS, MS
CONTACT
A
Alana Koehler, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here